ExodusPoint Capital Management’s Korro Bio KRRO Stock Holding History

ExodusPoint Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41,257	Closed	-$1.38M	–	1788
2024 Q3	$1.38M	Sell	41,257 -14,671	-26%	-$617K	0.01%	864
2024 Q2	$1.89M	Buy	55,928 +15,026	+37%	+$830K	0.01%	798
2024 Q1	$3.68M	Buy	40,902 +35,292	+629%	+$1.93M	0.03%	485
2023 Q4	$269K	Buy	+5,610	New	+$185K	﹤0.01%	1210
2022 Q2	–	Sell	-285	Closed	-$30K	–	2200
2022 Q1	$30K	Buy	+285	New	+$54.4K	﹤0.01%	2091
2021 Q4	–	Sell	-530	Closed	-$187K	–	2397
2021 Q3	$187K	Buy	+530	New	+$209K	﹤0.01%	1799
2020 Q2	–	Sell	-558	Closed	-$497K	–	1910
2020 Q1	$497K	Buy	+558	New	+$602K	0.03%	487

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ExodusPoint Capital Management's KRRO Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of Korro Bio (KRRO) in Q4 2024, closing a stake of 41,257 shares — an estimated $1.38M sold.

ExodusPoint Capital Management first reported a position in KRRO in Q1 2020 and held it in 7 quarters. The position peaked at $3.68M in Q1 2024. 84 funds tracked by Wall St. Rank hold KRRO as of Q4 2024.

ExodusPoint Capital Management reported no remaining Korro Bio position as of Q4 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 41,257 Korro Bio shares in Q4 2024, an estimated $1.38M.
ExodusPoint Capital Management first reported a position in Korro Bio in Q1 2020 and held it in 7 quarters.
ExodusPoint Capital Management's Korro Bio position peaked at $3.68M in Q1 2024.
84 funds tracked by Wall St. Rank held Korro Bio as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.